The Diabetes Attitudes Wishes and Needs (DAWN)-SMI study: A cross sectional comparison of the psychosocial impact of diabetes in adults with and without severe mental illness

IF 3.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Richard I. G. Holt, Heather Peyrot-Stuckey, Dankmar Böhning, Jo Taylor, Najma Siddiqi
{"title":"The Diabetes Attitudes Wishes and Needs (DAWN)-SMI study: A cross sectional comparison of the psychosocial impact of diabetes in adults with and without severe mental illness","authors":"Richard I. G. Holt,&nbsp;Heather Peyrot-Stuckey,&nbsp;Dankmar Böhning,&nbsp;Jo Taylor,&nbsp;Najma Siddiqi","doi":"10.1111/dme.70126","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>People with severe mental illness (SMI) are 2–3 times more likely to have diabetes than the general population. Little is known about the impact of living with diabetes for people with SMI. This study investigates psychosocial problems and diabetes self management for people with SMI and diabetes.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We compared cross sectional survey data collected from 258 adults with diabetes and SMI in England with 500 adults with diabetes from the UK sample of the second Diabetes Attitudes, Wishes and Needs study (DAWN2). Effect size (ES) tests were used to quantify differences between the two samples adjusted for diabetes type, age, gender, treatment, treatment duration, diabetes complications and co-morbidities to achieve comparability of the two samples.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Compared to the DAWN2-UK sample, people with diabetes and SMI reported poorer quality of life (WHOQOL ES −0.3 (CI −0.5, −0.1), <i>p</i> &lt; 0.001), mental well-being (ES −13.4 (CI −17.3, −9.5), <i>p</i> &lt; 0.001) and increased diabetes distress (PAID5 ES 1.6 (CI 0.9,2.3), <i>p</i> &lt; 0.001). While people with diabetes and SMI reported a negative impact from diabetes, their SMI had a greater impact on their lives than diabetes (mental illness impact profile 2.6 ± 1.1 vs. diabetes impact profile 3.4 ± 1.0, <i>p</i> &lt; 0.001). People with SMI reported being less engaged in self management than the DAWN2-UK population (SDSCA-6; ES −0.4 (CI −0.7, −0.1), <i>p</i> = 0.01).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The psychosocial impact of diabetes is greater for people with SMI. To reduce inequalities in diabetes outcomes, people with SMI and diabetes require tailored support for diabetes management that considers the additional challenges associated with living with a severe mental illness.</p>\n </section>\n </div>","PeriodicalId":11251,"journal":{"name":"Diabetic Medicine","volume":"42 10","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dme.70126","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetic Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/dme.70126","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aims

People with severe mental illness (SMI) are 2–3 times more likely to have diabetes than the general population. Little is known about the impact of living with diabetes for people with SMI. This study investigates psychosocial problems and diabetes self management for people with SMI and diabetes.

Methods

We compared cross sectional survey data collected from 258 adults with diabetes and SMI in England with 500 adults with diabetes from the UK sample of the second Diabetes Attitudes, Wishes and Needs study (DAWN2). Effect size (ES) tests were used to quantify differences between the two samples adjusted for diabetes type, age, gender, treatment, treatment duration, diabetes complications and co-morbidities to achieve comparability of the two samples.

Results

Compared to the DAWN2-UK sample, people with diabetes and SMI reported poorer quality of life (WHOQOL ES −0.3 (CI −0.5, −0.1), p < 0.001), mental well-being (ES −13.4 (CI −17.3, −9.5), p < 0.001) and increased diabetes distress (PAID5 ES 1.6 (CI 0.9,2.3), p < 0.001). While people with diabetes and SMI reported a negative impact from diabetes, their SMI had a greater impact on their lives than diabetes (mental illness impact profile 2.6 ± 1.1 vs. diabetes impact profile 3.4 ± 1.0, p < 0.001). People with SMI reported being less engaged in self management than the DAWN2-UK population (SDSCA-6; ES −0.4 (CI −0.7, −0.1), p = 0.01).

Conclusions

The psychosocial impact of diabetes is greater for people with SMI. To reduce inequalities in diabetes outcomes, people with SMI and diabetes require tailored support for diabetes management that considers the additional challenges associated with living with a severe mental illness.

Abstract Image

糖尿病态度、愿望和需求(DAWN)-SMI研究:糖尿病对患有和不患有严重精神疾病的成年人的社会心理影响的横断面比较。
目的:重度精神疾病(SMI)患者患糖尿病的可能性是一般人群的2-3倍。患有糖尿病对重度精神障碍患者的影响知之甚少。本研究探讨重度精神病人和糖尿病患者的社会心理问题和糖尿病自我管理。方法:我们比较了英国258名成人糖尿病和重度精神障碍患者和英国500名成人糖尿病患者的横断面调查数据,这些数据来自第二届糖尿病态度、愿望和需求研究(DAWN2)。采用效应量(ES)检验来量化两个样本之间的差异,调整糖尿病类型、年龄、性别、治疗、治疗持续时间、糖尿病并发症和合并症,以实现两个样本的可比性。结果:与DAWN2-UK样本相比,糖尿病和重度精神障碍患者报告的生活质量较差(WHOQOL ES -0.3 (CI -0.5, -0.1), p)。结论:糖尿病对重度精神障碍患者的社会心理影响更大。为了减少糖尿病预后的不平等,重度精神障碍患者和糖尿病患者需要为糖尿病管理提供量身定制的支持,以考虑与严重精神疾病患者生活相关的额外挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetic Medicine
Diabetic Medicine 医学-内分泌学与代谢
CiteScore
7.20
自引率
5.70%
发文量
229
审稿时长
3-6 weeks
期刊介绍: Diabetic Medicine, the official journal of Diabetes UK, is published monthly simultaneously, in print and online editions. The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans. Categories of publication include research articles, reviews, editorials, commentaries, and correspondence. All material is peer-reviewed. We aim to disseminate knowledge about diabetes research with the goal of improving the management of people with diabetes. The journal therefore seeks to provide a forum for the exchange of ideas between clinicians and researchers worldwide. Topics covered are of importance to all healthcare professionals working with people with diabetes, whether in primary care or specialist services. Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to know diabetes better and fight diabetes more effectively on behalf of all people affected by and at risk of diabetes as well as their families and carers.”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信